PubMed · 2018 · 18 citations · 10 references
Life SciencesInfectious DiseasesPharmacologyAntimicrobial ResistanceDrug DiscoveryMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibiotic ResistanceMultidrug ResistanceAntimicrobial Resistance In GonorrheaBacterial Multidrug ResistanceCeftriaxone TherapyMultidrug Resistance ManagementMultidrug-resistant PathogensNeisseria Gonorrhoeae ResistanceOvercoming Multidrug Resistance
becomes a public health problem worldwide, especially the strain H041 that showed the decrease susceptibility to ceftriaxone which is the last resort for gonorrhea treatment. Therefore, the simultaneous discovery and development of a new compound to fight this pathogen is urgently required. In this study, 8-hydroxyquinoline (8HQ) and derivatives were evaluated for their antimicrobial activities against the gonococcal pathogen using spectinomycin as the reference drug. The results showed that 8HQ derivatives gave an excellent antimicrobial potency. Particularly, the dihalogenated 8HQ (iodoquinol, clioquinol and 5,7-diCl-8HQ) exerted the high activity with MIC range of 0.08-0.15 μM, 0.10-0.20 μM and 0.28-0.56 µM, respectively, compared with the reference drug (MIC = 16 μg/mL or 48.14 μM). Moreover, these compounds were also shown to be non-cytotoxic/very high safety index. The findings reveal that these three compounds could be further developed as a new antimicrobial agent for fighting the gonorrheal disease.
10
Makoto Ohnishi, Daniel Golparian, Ken Shimuta et al. · Antimicrobial Agents and Chemotherapy · 2011 · 690 citations · Full text
Magnus Unemo, Oskar Fasth, H Fredlund et al. · Journal of Antimicrobial Chemotherapy · 2009 · 229 citations · Full text
Rungrot Cherdtrakulkiat, Somchai Boonpangrak, Nujarin Sinthupoom et al. · Biochemistry and Biophysics Reports · 2016 · 123 citations · Full text